Journal of Hepatology
Volume 39, Issue 2 , Pages 179-186 , August 2003

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease

  • Camilla Nøjgaard

      Affiliations

    • Department of Gastroenterology and Alcohol Unit, Hvidovre Hospital, Hvidovre, Denmark
    • Department of Clinical Physiology and Nuclear Medicine, Hvidovre Hospital, Hvidovre, Denmark
    • Corresponding Author InformationCorresponding author. Department of Medicine, Roskilde Amts Sygehus Køge, Lykkebækvej 1, 4600 Køge, Denmark
    • ,
  • Julia S Johansen

      Affiliations

    • Department of Rheumatology, Hvidovre Hospital, Hvidovre, Denmark
    • ,
  • Erik Christensen

      Affiliations

    • Clinic of Internal Medicine 1, Bispebjerg Hospital, Copenhagen, Denmark
    • ,
  • Lene Theil Skovgaard

      Affiliations

    • Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Paul A Price

      Affiliations

    • Department of Biology, University of California, San Diego, La Jolla, CA, USA
    • ,
  • Ulrik Becker

      Affiliations

    • Department of Gastroenterology and Alcohol Unit, Hvidovre Hospital, Hvidovre, Denmark
    • ,
  • The EMALD Group

Received 12 November 2002 ,Revised 18 March 2003 ,Accepted 2 April 2003.

References 

  1. Baptista A, Bianchi L, de Groote J, Desmet VJ, Gedigk P, Korb GM, et al.  Alcoholic liver disease: morphological manifestations. Lancet. 1981;28:707–711
  2. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L. Prognostic factors in alcoholic liver disease. Am J Gastroenterol. 1991;86:210–216
  3. Friedman SL. The cellular basis of hepatic fibrosis – mechanisms and treatment strategies. N Engl J Med. 1993;328:1828–1835
  4. Friedman SL. Stellate cell activation in alcoholic fibrosis – an overview. Alcohol Clin Exp Res. 1999;23:904–910
  5. Torres-Salinas M, Parés A, Caballerı́a J, Jiménez W, Heredia D, Bruguera M, et al.  Serum procollagen Type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology. 1986;90:1241–1246
  6. Rosman AS, Lieber CS. Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem. 1994;40:1641–1651
  7. Christensen E, Schlichting P, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N. Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance. Hepatology. 1985;5:843–853
  8. Keiding S, Badsberg JH, Becker U, Bentsen KD, Bonnevie O, Caballeria J, et al.  The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival. J Hepatol. 1994;20:454–460
  9. Møller S, Becker U, Juul A, Skakkebæk NE, Christensen E. Prognostic value of insulin-like growth factor I and its binding protein in patients with alcohol-induced liver disease. Hepatology. 1996;23:1073–1078
  10. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem. 1993;268:25803–25810
  11. Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJT. Gp38k, a protein synthesized by vascular smooth muscle cells stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res. 1999;250:168–173
  12. De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoreau P. YKL-40 (Cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001;285:926–931
  13. Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002;365:119–126
  14. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human Type III procollagen. Clin Chem. 1988;34:715–718
  15. Bentsen KD, Henriksen JH, Bendtsen F, Hørslev-Petersen K, Lorenzen I. Splanchnic and renal extraction of circulating Type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology. 1990;11:957–963
  16. Johansen JS, Christoffersen P, Møller S, Price PA, Henriksen JH, Garbarsch C, et al.  Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol. 2000;32:911–920
  17. Johansen JS, Møller S, Price PA, Bendtsen F, Junge J, Garbarsch C, et al.  Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?. Scand J Gastroenterol. 1997;32:582–590
  18. Nouchi T, Worner TM, Sato S, Lieber CS. Serum procollagen Type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res. 1987;11:287–291
  19. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aubé C, et al.  Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology. 1997;113:1609–1616
  20. Trinchet J-C, Hartmann DJ, Pateron D, Munz-Gotheil C, Callard P, Ville G, et al.  Serum Type I collagen and N-terminal peptide of Type III procollagen in patients with alcoholic liver disease: relationship to liver histology. Alcohol Clin Exp Res. 1992;16:342–346
  21. Tran A, Benzaken S, Saint-Paul M-C, Guzman-Granier E, Hastier P, Pradier C, et al.  Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol. 2000;12:989–993
  22. Bentsen KD, Horn T, Risteli J, Risteli L, Engström-Laurent A, Hørslev-Petersen K, et al.  Serum aminoterminal Type III procollagen peptide and the 7S domain of Type IV collagen in patients with alcohol abuse. Liver. 1987;7:339–346
  23. Shahin M, Schuppan D, Waldherr R, Risteli J, Risteli L, Savolainen E-R, et al.  Serum procollagen peptides and collagen Type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology. 1992;15:637–644
  24. Stickel F, Urbaschek R, Schuppan D, Poeschl G, Oesterling C, Conradt C, et al.  Serum collagen Type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Dig Dis Sci. 2001;46:2025–2032
  25. Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol. 1996;35:553–559
  26. Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol. 1993;32:949–955
  27. Poulsen H, Christoffersen P. Atlas of liver biopsies. Copenhagen: Munksgaard; 1979;
  28. Christensen E. Multivariate survival analysis using Cox's regression model. Hepatology. 1987;7:1346–1358
  29. Grønbæk M, Deis A, Sørensen TIA, Becker U, Borch-Johnsen K, Müller C, et al.  Influence of sex, age, body mass index and smoking on alcohol intake and mortality. Br Med J. 1994;308:302–308
  30. Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, et al.  Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem. 1998;251:504–509
  31. Volck B, Price PA, Johansen JS, Sørensen O, Benfield TL, Nielsen HJ, et al.  YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians. 1998;110:351–360
  32. Takai KK, Hattori S, Irie S. Type V collagen distribution in liver is reconstructed in coculture system of hepatocytes and stellate cells; the possible functions of Type V collagen in liver under normal and pathological conditions. Cell Struct Funct. 2001;26:289–302
  33. Smedsrød B. Aminoterminal propeptide of Type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Coll Relat Res. 1988;8:375–388
  34. Parés A, Deulofeu R, Giménez A, Caballerı́a L, Bruguera M, Caballerı́a J, et al.  Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology. 1996;24:1399–1403
  35. Lawrance IC, Maxwell L, Doe W. Inflammation location, but not type, determines the increase in TGF-β1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis. 2001;7:16–26
  36. Aycock RS, Seyer JM. Collagens of normal and cirrhotic human liver. Connect Tissue Res. 1989;23:19–31
  37. Nord HJ. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques – a review. Gastrointest Endosc. 1982;28:102–104

PII: S0168-8278(03)00184-3

doi: 10.1016/S0168-8278(03)00184-3

Journal of Hepatology
Volume 39, Issue 2 , Pages 179-186 , August 2003

Article Tools

* Image Usage & Resolution